November 2019

ONCOLOGY

IMPROVING SURVIVAL OUTCOMES FOR MELANOMA PATIENTS

Featuring: Jeffrey Wayne MD, FACS

Episode Summary

According to the American Cancer Society, rates of melanoma have been rising rapidly over the past few decades with an estimated 96,480 cases diagnosed in 2019 alone. Joining me today is Dr. Jeffrey Wayne, chief of Surgical Oncology at Northwestern Medicine and the associate director for clinical affairs at the Robert H. Lurie Comprehensive Cancer Center at Northwestern University. Dr. Wayne is here today to share the latest advances and treatment of melanoma.

This article was originally published in the Feinberg School of Medicine News Center on November 5, 2019.
Jeffrey Wayne MD, FACS, is the chief of Surgical Oncology at Northwestern Medicine and the associate director for clinical affairs at the Robert H. Lurie Comprehensive Cancer Center at Northwestern University. Dr. Wayne specializes in treatment of all stages of melanoma and soft tissue sarcoma. He earned his medical degree at Boston University, completed residency at the University of Chicago Hospitals and a fellowship at University of Texas MD Anderson Hospital. Dr. Wayne has published more than 85 peer-reviewed papers and has received numerous teaching awards.

Refer a Patient

Northwestern Medicine welcomes the opportunity to partner with you in caring for your patients. ​

You May Also Like